Tumor necrosis factor α and interleukin 1β enhance the cortisone/cortisol shuttle

Journal of Experimental Medicine

Volumn 186, Issue 2, 1997, Pages 189-198

  Escher, Geneviève ^a   Galli, Ivo ^a   Vishwanath, Bannikuppe S ^a   Frey, Brigitte M ^a   Frey, Felix J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CORTISONE; GLUCOCORTICOID; HYDROCORTISONE; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; HORMONE ACTION; INFLAMMATION; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ANIMALS; CORTISONE; GLOMERULAR MESANGIUM; HYDROCORTISONE; HYDROXYSTEROID DEHYDROGENASES; INTERLEUKIN-1; PHOSPHOLIPASES A; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030749702     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.186.2.189     Document Type: Article

References (57)

1. Okusawa, S., J.A. Gelfand, T. Ikejima. R.J. Connolly, and C.A. Dinarello. 1988. Interleukin 1 induces a shock-like state in rabbits: synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J. Clin. Invest. 81:1162-1172.
2. Mandrup-Poulsen, T.K., K. Bentzen, C.A. Dinarello, and J. Nerup. 1987. Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity. J. Immunol. 139:4077-4082.
3. Elias, J.A., K. Gustilo, W. Baeder, and B. Freundlich. 1987. Synergistic stimulation of fibroblast prostaglandin production by recombinant interleukin 1 and tumor necrosis factor. J. Immunol. 138:33813-33816.
4. Vishwanath, B.S., F.J. Frey, M.J. Bradbury, M.F. Dallman, and B.M. Frey. 1993. Glucocorticoid deficiency increases phospholipase A2 activity in rats. J. Clin. Invest. 92:1974-1980.
5. Nakano, T.O., O. Ohara, H. Teraoka, and H. Arita. 1990. Glucocorticoids suppress group II phospholipase A2 production by blocking mRNA synthesis and posttranscriptional expression. J. Biol. Chem. 265:12745-12748.
6. Pfeilschifter, J., C. Schalkwijk, V.A. Briner, and H. van den Bosch. 1993. Cytokine-stimulated secretion of group II PLA2 by rat mesangial cells. J. Clin. Invest. 92:2516-2523.
7. Nakano, T., O. Ohara, H. Teraoka, and H. Arita. 1990. Group II phospholipase A2 mRNA synthesis is stimulated by two distinct mechanisms in rat vascular smooth muscle cells. FEBS Lett. 261:171-174.
8. Funder, J.W., P.T. Pearce, R. Smith, and A.I. Smith. 1988. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science (Wash. DC). 242:583-585.
9. Frey, F.J. 1987. Kinetics and dynamics of prednisolone. Endocr. Rev. 8:453-473.
10. Escher, G., F.J. Frey, and B.M. Frey. 1994. 11β-hydroxysteroid dehydrogenase accounts for low prednisolone/prednisone ratios in the kidney. Endocrinology. 135:101-106.
11. Agarwal, A.K., C. Monder, B. Eckstein, and P.C. White. 1989. Cloning and expression of rat cDNA encoding corticosteroid 11β-hydroxysteroid dehydrogenase. J. Biol. Chem. 264:18939-18943.
12. Albitson, A.L., V.R. Obeyesekere, R.E. Smith, and Z. Krozowski. 1994. Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme. Mol. Cell. Endocrinol. 105:R11-R17.
13. Stewart, P.M., Z.S. Krozowski, A. Gupta, D.V. Milford, A.J. Howie, M.C. Sheppard, and C.B. Whorwood. 1996. Human hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11β-hydroxysteroid dehydrogenase type 2 gene. Lancet. 1:88-91.
14. Ferrari, P., V.R. Obeyesekere, K. Li, R.C. Wilson, M.I. New, J.W. Funder, and Z.S. Krozowski. 1996. Point mutation abolish 11β-hydroxysteroid dehydrogenase type II activity in three families with the congenital syndrome of apparent mineralocorticoid excess. Mol. Cell. Endocrinol. 119:21-24.
15. Agarwal, A.K., M.T. Tusie-Luna, C. Monder, and P.C. White. 1990. Expression of 11β-hydroxysteroid dehydrogenase using recombinant vaccinia virus. Mol. Endocrinol. 4: 1827-1832.
16. Konieczkowski, M., and J.R. Sedor. 1993. Cell-specific regulation of type II PLA2 expression in rat mesangial cells. J. Clin. Invest. 92:2524-2532.
17. Schlondorff, D. 1987. The glomerular mesangial cell: an expanding role for a specialized pericyte. FASEB (Fed. Am. Soc. Exp. Biol.) J. 1:272-281.
18. Striker, L.J., E.P. Peten, S.J. Elliot, T. Doi, and G.E. Striker. 1991. Mesangial cell turnover: effect of heparin and peptide growth factors. Lab. Invest. 64:446-456.
19. Escher, G., K.V. Meyer, B.S. Vishwanath, B.M. Frey, and F.J. Frey. 1995. Furosemide inhibits 11β-hydroxysteroid dehydrogenase in vitro and in vivo. Endocrinology. 136:1759-1765.
20. Lovett, D.H., R.B. Sterzel, M. Kashgarian, and J.L. Ryan. 1983. Neutral proteinase activity produced in vitro by cells of the glomerular mesangium. Kidney Int. 23:342-349.
21. Satoh, K., I. Galli, and H. Ariga. 1993. Effect of drugs on gene expression in mammalian cells: a highly efficient procedure to test large numbers of samples. Nucleic Acids Res. 21: 4429-4430.
22. Monder, C., V. Lakshmi, and Y. Miroff. 1991. Kinetic studies on rat liver 11β-hydroxysteroid dehydrogenase. Biochim. Biophys. Acta. 1115:23-29.
23. Duncan, L.J., N.G. Coldham, and M.J. Reed. 1994. The interaction of cytokines in regulating oestradiol 17β-hydroxysteroid dehydrogenase activity in MCF-7 cells. J. Steroid Biochem. Mol. Biol. 49:63-68.
24. Vishwanath, B.S., F.J. Frey, G. Escher, J. Reichen, and D.M. Frey. 1996. Liver cirrhosis induces renal and liver phospholipase A2 activity in rats. J. Clin. Invest. 98:365-371.
25. Patriarca, P., S. Beckerdite, and P. Elsbach. 1972. Phospholipases and phospholipid turnover in Escherichia coli spheroplasts. Biochim. Biophys. Acta. 260:593-600.
26. Vishwanath, B.S., C.A. Fux, D.E. Uehlinger, B.M. Frey, R.C. Franson, and F.J. Frey. 1996. Hemodialysis activates phospholipase A2 enzyme. Nephrol. Dial. Transplant. 11: 106-116.
27. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenolchloroform extraction. Anal. Biochem. 162:156-159.
28. Muller, S., and H.J. Seitz. 1994. Cloning of a cDNA for the FAD-linked glycerol-3-phosphate dehydrogenase from rat liver and its regulation by thyroid hormones. Proc. Natl. Acad. Sci. USA. 91:10581-10585.
29. Monder, C., P.M. Stewart, V. Lakshmi, R. Valentine, D. Burt, and C.R.W. Edwards. 1989. Licorice inhibits corticosteroid 11β-hydroxysteroid dehydrogenase of rat kidney and liver: in vivo and in vitro studies. Endocrinology. 125:1046-1053.
30. Pfeilschifter, J., W. Pignat, K. Vosbeck, and F. Märki. 1989. Interleukin 1 and tumor necrosis factor synergistically stimulate prostaglandin synthesis and phospholipase A2 release from rat mesangial cells. Biochem. Biophys. Res. Commun. 159: 385-394.
31. Nakazato, Y., M.S. Simonson, W.H. Herman, M. Konieczkowski, and J.R. Sedor. 1991. Interleukin-1α stimulates prostaglandin biosynthesis in serum-activated mesangial cells by induction of a non-pancreatic (Type II) phospholipase A2. J. Biol. Chem. 266:14119-14127.
32. Topley, N., J. Floege, K. Wessel, R. Hass, H.H. Radeke, V. Kaever, and K. Resch. 1989. Prostaglandin E2 production is synergistically increased in cultured human glomerular mesangial cells by combinations of IL-1 and tumor necrosis factor-α. J. Immunol. 143:1989-1995.
33. Besedovsky, H., A. del Rey, E. Sorkin, and C. Dinarello. 1986. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science (Wash. DC). 233:652-654.
34. Sapolsky, R., C. Rivier, G. Yamamoto, P. Plotsky, and W. Vale. 1987. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science (Wash. DC). 238: 522-524.
35. Krozowski, Z., A.L. Albitson, V.R. Obeyesekere, R.K. Andrews, and R.E. Smith. 1995. The human 11β-hydroxysteroid dehydrogenase type II enzyme: comparisons with other species and localization to the distal nephron. J. Steroid Biochem. Mol. Biol. 5:457-464.
36. Krozowski, Z., J.A. Maguire, A.N. Stein-Oakley, J. Dowling, R.E. Smith, and R.K. Andrews. 1995. Immunohistochemical localization of the 11β-hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta. J. Clin. Endocrinol. Metab. 80:2203-2209.
37. Schalkwijk, C., J. Pfeilschifter, F. Märki, and H. van den Bosch. 1991. Interleukin-1β, tumor necrosis factor and stimulate the synthesis and secretion of group II PLA2 and prostaglandin E2 in rat mesangial cells. Biocliem. Biophys. Res. Commun. 174:268-275.
38. Nakano, T., O. Ohara, H. Teraoka, and H. Arita. 1990. Group II phospholipase A2 mRNA synthesis is stimulated by two distinct mechanisms in rat vascular smooth muscle cells. FEBS Lett. 261:171-174.
39. Nakano, T., and H. Arita. 1990. Enhanced expression of group II phospholipase A2 gene in the tissues of endotoxin shock rats and its suppression by glucocorticoids. FEBS Lett. 273:23-26.
40. Inoue, H., H. Saito, Y. Koshihara, and S. Murota. 1986. Inhibitory effect of glycyrrhetinic acid derivatives on lipoxygenase and prostaglandin synthetase. Chem. Pharm. Bull. (Tokyo). 34: 897-901.
41. D'Arcy, P.F., and D.N. Kellet. 1957. Glycyrrhetinic acid. Br. Med. J. 1:647.
42. Kumar, A., V. Thota, L. Dee, J. Olson, E. Uretz, and J.E. Parillo 1996. Tumor necrosis factor α and interleukin 1β are responsible for in vitro myocardial cell depression induced by human septic shock serum. J. Exp. Med. 183:949-958.
43. Waage, A., and T. Espevik. 1988. Interleukin-1 potentiates the lethal effect of tumor necrosis factor α/cachectin in mice. J. Exp. Med. 167:1987-1992.
44. Werber, H.I., S.N. Emancipator, M.L. Tyrocinski, and J.R. Sedor. 1987. The interleukin 1 gene is expressed by rat glomerular mesangial cells and is augmented in immune complex glomerulonephritis. J. Immunol. 138:3207-3212.
45. Diamond, J.R., and I. Pesek. 1991. Glomerular tumor necrosis factor and interleukin 1 during acute aminonucleoside nephrosis. An immunohistochemical study. Lab. Invest. 64: 21-28.
46. Tipping, P.G., M.G. Lowe, and S.R. Holdsworth. 1991. Glomerular interleukin 1 production is dependent on macrophage infiltration in anti-GBM glomerulonephritis. Kidney Int. 39:103-110.
47. Boswell, J.M., M.A. Yui, S. Endres, D.W. Burt, and V.E. Kelley. 1988. Novel and enhanced IL-1 gene expression in autoimmune mice with lupus. J. Immunol. 141:118-124.
48. Matsumoto, K., J. Dowling, and R.C. Atkins. 1988. Production of interleukin 1 in glomerular cell cultures from patients with rapidly progressive crescentic glomerulonephritis. Am. J. Nephrol. 8:463-470.
49. Nakamura, T., I. Ebihara, M. Fukui, T.T. Takaahashi, Y. Tomino, and H. Koide. 1993. Altered glomerular steady-state levels of tumor necrosis factor α mRNA during nephrotic and sclerotic phases of puromycin aminonucleoside nephrosis in rats. Clin. Sci. (Lond.). 84:349-356.
50. Bour, E.S., L.K. Ward, G.A. Cornman, and H.C. Isom. 1996. Tumor necrosis factor-α-induced apoptosis in hepatocytes in long-term culture. Am. J. Pathol. 148:485-495.
51. Groux, H., D. Monte, B. Plouvier, A. Capron, and J.C. Ameisen. 1993. CD3-mediated apoptosis of human medullary thymocytes and activated peripheral T cells: respective roles of interleukin-1, interleukin-2, interferon-γ and accessory cells. Eur. J. Immunol. 23:1623-1629.
52. Helmberg, A., N. Auphan, C. Caelles, and M. Kann. 1995. Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO (Eur. Mol. Biol. Organ.) J. 14:452-460.
53. Frey, B.M., C. Walker, F.J. Frey, and A.L. de Weck. 1984. Pharniacokinetics and pharmacodynamics of three different prednisolone prodrugs: effect on circulating lymphocyte subsets and function. J. Immunol. 133:2479-2487.
54. Knudsen, P.J., C.A. Dinarello, and T.B. Strom. 1987. Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells. J. Immunol. 139:4129-4134.
55. Scheinman, R.L., P.C. Cogswell, A.K. Lofquist, and A.S. Baldwin. 1995. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science. (Wash. DC). 270:283-286.
56. Auphan, N., J.A. DiDonato, C. Rosette, A. Helmberg, and M. Karin. 1995. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of 1KB synthesis. Science. 270:286-290.
57. Devchand, P.R., H. Keller, J.M. Peters, M. Vazquez, F.J. Gonzales, and W. Wahli. 1996. The PPARα-leukotriene B4 pathway to inflammation control. Nature (Lond.). 384:39-43.